Result Pages: 1
2
3
[Next
>>]
Victory for Health Freedom
An unmissable sight on Monday morning was
the giant placard held aloft outside the Federal Office for
Consumer Protection and Veterinary Medicine (Bundesamt für
Verbraucherschutz und Veterinärmedizin (BgVV)) in the
Marienfelde district of Berlin: "60 million say "No" to the
Codex plans"
full
article
US Lawyer Says Seeks Worldwide Case Against
Bayer
BERLIN (Reuters) - An American lawyer suing
pharmaceutical giant Bayer AG over its recalled drug Baycol
said on Friday he would try to expand the suit to embrace
cases worldwide and had also included another industry
heavyweight, GlaxoSmithKline Plc, in the action.
full
article
Bayer Drops as U.S. Listing in Doubt
FRANKFURT (Reuters) - Germany's biggest
drugs group Bayer AG hinted on Thursday it could call off its
planned New York listing next month as U.S lawsuits related to
the recalled Baycol drug hammered its share price.
full
article
For Over Twelve years, Bayer knew of the
dangers of Cholesterol-lowering Drugs
The disastrous damages spawned by
cholesterol-lowering drugs are no surprise to the
pharmaceutical industry. On the contrary, the pharma-giants
have known for over twelve years that cholesterol-lowering
drugs block the synthesis of the vital nutrient Coenzyme
Q10.
full
article
Baycol News Prompts EU Review of
Cholesterol Drugs
LONDON (Reuters) - The European Medicines
Evaluation Agency announced on Thursday a safety review of
other drugs in the same class as Bayer AG's
cholesterol-lowering agent Baycol, which was withdrawn after
being linked to 31 deaths in the United States.
full
article
FDA Says Withdrawn Bayer Drug Linked to 31
Deaths
WASHINGTON (Reuters) -
Bayer AG's cholesterol drug Baycol, which the German drug
giant pulled from the market Wednesday, is linked to 31 US
deaths from a muscle-related side effect, according to the US
Food and Drug Administration (FDA).
(Editors Note: Baycol was due to generate sales of over
$875 million this year. A long known side effect of this class
of cholesterol lowering drugs is the depletion of the
essential nutrient Coenzyme Q10 in heart muscle cells. For
over 15 years pharmaceutical companies held and continue to
hold patents to add Q10 to cholesterol lowering drugs to avoid
this long known side effect, but refused until today to use
it.)
full
article
Fight Cholesterol When Young, But Not When
Older?
August 3 (CBS HealthWatch) With a nasty
reputation for clogging arteries and causing heart attacks,
there is little doubt that cholesterol is public health enemy
number one. But a perplexing new study suggests that
authorities may have nabbed the wrong suspect, at least where
the elderly are concerned.
full
article
Heart Group Urges Caution on Estrogen
Therapy
WASHINGTON (Reuters) - Doctors should not
prescribe hormone replacement drugs to post-menopausal women
with the single purpose of trying to ward off heart attack or
stroke, the American Heart Association said on Monday.
full
article
Hormones Risky for Women with Heart
Disease
NEW YORK (Reuters Health) - Although hormone
replacement therapy (HRT) has been thought to protect women's
hearts after menopause, two new studies confirm that for women
with heart disease, HRT can temporarily raise the risk of
heart attack and death.
full
article
Muscle Weakness: Bayer Changes Label of
Cholesterol Drug
WASHINGTON (Reuters Health) - Bayer Corp.,
the American subsidiary of Germany's Bayer AG, has amended the
label of its cholesterol-lowering drug Baycol (cerivastatin)
due to reports of patients experiencing muscle weakness,
according to a US Food and Drug Administration (FDA) notice
issued on Tuesday.
full
article
Result Pages: 1
2
3
[Next
>>]
